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To isolate a gene for stimulating avermectin production, a genomic library of Streptomyces avermitilis ATCC
31267 was constructed in Streptomyces lividans TK21 as the host strain. An 8.0-kb DNA fragment that
significantly stimulated actinorhodin and undecylprodigiosin production was isolated. When wild-type S.
avermitilis was transformed with the cloned fragment, avermectin production increased approximately 3.5-fold.
The introduction of this fragment into high-producer (ATCC 31780) and semi-industrial (L-9) strains also
resulted in an increase of avermectin production by more than 2.0- and 1.4-fold, respectively. Subclones were
studied to locate the minimal region involved in stimulation of pigmented-antibiotic and avermectin produc-
tion. An analysis of the nucleotide sequence of the entire DNA fragment identified eight complete and one
incomplete open reading frame. All but one of the deduced proteins exhibited strong homology (68 to 84%
identity) to the hypothetical proteins of Streptomyces coelicolor A3(2). The orfX gene product showed no
significant similarity to any other protein in the databases, and an analysis of its sequence suggested that it
was a putative membrane protein. Although the nature of the stimulatory effect is still unclear, the disruption
of orfX revealed that this gene was intrinsically involved in the stimulation of avermectin production in S.
avermitilis.
Recent studies on various Streptomyces species have shown
that many regulatory factors are involved in creating a complex
network, which then influences the morphological differentia-
tion and production of secondary metabolites. Such regulatory
cascades are consistent with the need of Streptomyces spp. to
interact with a variety of environmental changes (3). If the
regulatory mechanism of antibiotic biosynthesis can be wholly
understood and tightly controlled, this could be a starting point
for replacing mutagenesis by UV irradiation or mutagen treat-
ment and the consecutive screening of high-producer strains
for improving the productivity of antibiotic biosynthesis. Un-
fortunately, however, the molecular processes regulating the
events leading to differentiation and simultaneous antibiotic
biosynthesis are still poorly understood, despite the discovery
of numerous useful insights into Streptomyces genetics.
For example, most of the genetic factors regulating avermec-
tin production have not been clearly elucidated, even though
avermectin and the avermectin-producing species Streptomyces
avermitilis are considered industrially valuable. Avermectin is
known to be an excellent anthelminthic agent and highly active
against a broad spectrum of nematode and arthropod parasites
(6, 15). As a result of its superior activity and widespread
market acceptance, the avermectin market exploded during
the 1980s and reached U.S. $1 billion at the end of the 1990s.
Recently, the nucleotide sequence of the avermectin biosyn-
thetic gene cluster and the entire genome of S. avermitilis were
completely determined (10, 19). The sequencing analysis
showed that the avermectin gene cluster spans a distance of 82
kb and has a putative pathway-specific regulatory gene, aveR
(10). The aveR product has sequence similarity with RapH in
the rapamycin biosynthetic gene cluster and ORF6 in the gene
111 cluster of Streptomyces hygroscopicus. However, despite the
completion of the S. avermitilis genome sequencing and the
continued accumulation of molecular biological information
on this strain, most of the genetic factors regulating avermectin
production remain unknown.
Accordingly, the present study describes the cloning, se-
quencing, and analysis of a putative regulatory fragment of S.
avermitilis that causes the overproduction of actinorhodin and
undecylprodigiosin in Streptomyces lividans TK21, which only
produces a basal level of the pigmented antibiotics under nor-
mal conditions. It is also shown that this fragment has a stim-
ulatory effect on avermectin production in various S. avermitilis
strains. A sequence analysis of the DNA fragment revealed
eight complete and one incomplete open reading frame (ORF)
containing a putative regulatory gene. The disruption of this
putative regulatory gene severely reduced avermectin produc-
tion.
MATERIALS AND METHODS
Bacterial strains and plasmids. Table 1 lists the bacterial strains and plasmids
used along with a summary of their characteristics. Three strains of S. avermitilis
were used: the wild-type strain ATCC 31267, a high-avermectin-producing mu-
tant, ATCC 31780, and a genetically unstable semi-industrial strain, L-9 (9). S.
lividans TK21 was used as both the cloning host and the host for the preparation
of all Streptomyces plasmids. Streptomyces plasmids pIJ702, pIJ487 (12), pIJ61
(25), and pIJ941 (14) were used to investigate the copy number effect on anti-
biotic production in both S. lividans and S. avermitilis. Escherichia coli strains
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DH5 and JM109 were used for general cloning (21). Plasmids pUC18 and
pUC19 were used for subcloning and sequencing (21).
Media and culture conditions. S. lividans was grown on R2YE agar plates or
in a YEME liquid medium (13). Wild-type S. avermitilis and its high-producing
mutants were maintained on Bennet’s agar or a YMG agar medium as a sporu-
lation medium (2). To prepare vegetative inocula, spores or mycelia from a plate
culture of S. avermitilis on YMG agar were added to 25 ml of liquid SM medium
composed of 30 g of glucose, 5 g of soybean meal, 30 g of yeast extract, 5 g of
peptone, and 3 g of malt extract per liter. The culture was incubated for 1 to 2
days at 30°C until the production of a melanin-like dark brown pigment started.
The avermectin production cultures were inoculated with 1.25 ml of SM culture
broth in a modified MF medium composed of 70 g of sucrose, 14 g of soybean
meal, 2.5 g of yeast extract, 0.1 g of NaCl, 1 g of CaCO3, 0.5 g of K2HPO4, and
10 g of MOPS (morpholinepropanesulfonic acid) per liter, and 50 glass beads
(0.5-mm diameter) were added to each flask. The fermentations were performed
in 300-ml baffled flasks on a rotary shaker (225 rpm) at 28°C.
When selecting S. avermitilis transformants, thiostrepton was used at a con-
centration of 10 g ml1 in agar medium and 1 g ml1 in liquid cultures. When
selecting S. lividans transformants, thiostrepton was used at a concentration of 50
g ml1 in agar medium and 5 g ml1 in liquid cultures. When selecting
gentamicin-resistant E. coli or Streptomyces strains, 20 g of gentamicin per ml
was used for both plate and liquid cultures.
Genomic library construction and DNA manipulations. Genomic DNA from
S. avermitilis ATCC 31267 was isolated with the method described by Kieser et
al. (13), and partial digestion of the isolated chromosomal DNA with Sau3AI was
optimized. Enriched fractions of 7.0-kb to 10.0-kb fragments were extracted from
the agarose gels, and the collected DNA was concentrated by ethanol precipi-
tation. The DNA was ligated into BglII-digested pIJ702, and the ligate was used
directly to transform S. lividans TK21 protoplasts. Standard protocols were used
for the transformation of S. lividans, plasmid isolation, and colony selection (13).
About 7,000 transformants were obtained and analyzed. The isolation of plasmid
DNA from E. coli was performed with a Promega Wizard Plus DNA purification
kit. The restriction enzymes were obtained from New England Biolabs, Promega,
or Boehringer Mannheim, and the digestions were performed according to the
manufacturers’ instructions.
Antibiotic production assays. For the detection of actinorhodin, the absor-
bance of the culture broth was measured at 590 nm with a spectrophotometer
after adjusting the supernatants to pH 12.0 with 1 M NaOH. Undecylprodigiosin
was extracted with methanol from the mycelium acidified with 1 M HCl, and the
absorption was measured at 530 nm (24). To analyze avermectin, a portion of the
culture broth (2 ml) was extracted with 2 ml of methanol by shaking vigorously
(300 rpm) for 30 min in a shaking incubator. After removing the methanol, the
residue was reextracted with an appropriate volume (0.2 to 2 ml) of dichlo-
romethane. The quantities of the major avermectin components were deter-
mined by high-pressure liquid chromatography (HPLC) with a Waters C18 col-
umn (3.9 by 150 mm) with methanol-water (85:15, vol/vol) as the mobile phase
(7, 18, 22). The elution times of the eight major components, monitored at an
absorbance of 246 nm, were 4.65 (B2b), 5.43 (B2a), 6.15 (A2b), 7.54 (A2a), 8.90
(B1b), 11.26 (B1a), 12.36 (A1b), and 16.20 (A1a) min, in the order of elution. An
authentic sample of avermectin was kindly provided by LG Biotech and used as
the internal standard.
DNA sequencing and nucleotide sequence analysis. The DNA sequence was
read at least two times with the primers indicated in Table 2 with a Perkin Elmer
Amplitaq dye terminator sequencing system with double-stranded DNA tem-
plates run on an Applied Biosystems 377 automated sequencer. The sequencing
reactions were initially performed from vector sequences with universal forward
and reverse primers, followed by specific primers generated from the initial
sequence data (Table 2). However, one region (bp 6200 to 7500) of the cloned
fragment produced unreadable signals when used in the so-called primer-walking
method. A high GC content (average, 74%) can cause such a problem, but the
reason was not clearly elucidated. For the sequencing of this region, nested
deletions with exonuclease III were generated with an Erase-a-Base kit from
Promega. Sequence homology searches were performed with the National Cen-
ter for Biotechnology Information worldwide BLAST server. The nucleotide
sequences were analyzed with PC GENE and FramePlot (11) software.
Insertional inactivation. The construction of an S. avermitilis ATCC 31267
mutant by gene disruption (Fig. 5) was accomplished by inserting a gentamicin
resistance cassette into the cloned orfX gene in vitro and replacing the chromo-
somal copy. First, a 1.8-kb SphI fragment of S4 containing orfX was subcloned
into pUC19 to create plasmid pS2S. A 1,080-bp PstI-EcoRI fragment containing
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Characteristics Reference(s)
Strains
S. avermitilis ATCC31267 Wild-type strain (avg avermectin production, 40–60 mg liter1) 9
S. avermitilis ATCC31780 High-producing strain derived from ATCC 31267 (avg avermectin
production, 160–200 mg liter1)
9
S. avermitilis L-9 Semi-industrial strain derived from ATCC 31267 (avg avermectin
production, 400–600 mg liter1)
9
S. lividans TK21 Cloning host (str-6 SLP2 SLP3) 16, 26
E. coli DH5, JM109 General cloning hosts 21
Plasmids
pIJ702 Streptomyces cloning vector with mel gene (100–300 copies) 12, 13
pIJ487 Streptomyces cloning vector (100–300 copies) 13
pIJ61 Streptomyces cloning vector (4–5 copies) 13, 25
pIJ941 Streptomyces cloning vector (1–2 copies) 13, 14
pUC18, pUC19 E. coli cloning and sequencing vectors 21
pHP45aac Source of aacC4 gene 5
pHP45aac Site-directed mutated aacC4 gene (aac) without XhoI site This study
pPRA2 pIJ702 containing 8.0-kb S2 fragment at BglII site This study
pPRA4 pIJ702 containing 3.6-kb SacI-PstI fragment (S4) of S1 This study
pNS1 pIJ487 containing 0.7-kb BamHI fragment (NS1) of S1 This study
pNS2 pIJ487 containing 3.3-kb SacI fragment (NS2) of S1 This study
pNS3 pIJ487 containing 1.8 kb SacI fragment (NS3) of S1 This study
pNS4 pIJ487 containing 3.2-kb SacI-BamHI fragment (NS4) of S1 This study
pUC-S18 pUC19 containing 1.8-kb SacI fragment (NS3) of S1 This study
pUC-S33 pUC19 containing 3.3-kb SacI fragment (NS2) of S1 This study
pUC-S36 pUC19 containing 3.6-kb SacI-PstI fragment (NS4) of S1 This study
pMS4 pIJ61 containing 2.7-kb BamHI-PstI fragment of S1 This study
pLS4 pIJ941 containing 3.6-kb EcoRI-PstI fragment of pUC-S36 This study
pS2S pUC19 containing 1.8-kb SphI fragment of S4 This study
pUC19-tsr pUC19 containing tsr gene on BclI fragment at BamHI site This study
pS2S-tsr pUC-S36 containing tsr gene isolated from pUC19-tsr This study
pS2S-tsr-aac pS2S-tsr containing PCR-amplified aac gene at XhoI site of orfX This study
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the thiostrepton resistance gene (tsr) from a pUC19 derivative plasmid, pUC19-
tsr, was inserted between the PstI and EcoRI sites in plasmid pS2S to construct
plasmid pS2S-tsr. To introduce a gentamicin resistance cassette into a unique
XhoI site in orfX, a 1,230-bp gentamicin resistance gene (aac) was amplified by
PCR with plasmid pHP45aac as the template. This plasmid was generated from
pHP45aac (5) by site-directed mutagenesis with a QuikChange kit from Strat-
agene, based on replacing an internal XhoI site of CTCGAG with CTGGAG.
The resulting plasmid, pS2S-tsr-aac, was used for the transformation of S. aver-
mitilis ATCC 31267.
The recombinant clones were produced by undergoing homologous recombi-
nation with the chromosomal copy of orfX and then selected for resistance to
gentamicin and sensitivity to thiostrepton. The selected recombinants were sub-
sequently grown without gentamicin on a modified YM agar plate. The gentam-
icin-resistant colonies containing orfX interrupted by a gentamicin resistance
gene were inoculated into medium containing gentamicin at a final concentration
of 20 g ml1. Confirmation of the final null mutant was achieved by PCR
analysis with internal primers S36F5 and S36R2 as described in standard proto-
cols.
RESULTS
Cloning of large DNA fragment activating pigment produc-
tion and selection of pigment-overproducing colonies. To iden-
tify the regulatory determinant biosynthetically activating quite
different antibiotic production in S. lividans and S. avermitilis,
a genomic library of S. avermitilis was constructed and trans-
formed into the heterologous host S. lividans TK21. This strain
includes all the gene sets required for the biosynthesis of ac-
tinorhodin and undecylprodigiosin, yet its pigment production
is very low compared to that of its close relative Streptomyces
coelicolor under normal conditions (16). In previous reports, S.
lividans TK21 has been proved to be an ideal host for this
purpose (16, 20, 26).
The genomic library of the pigment-overproducing S. livi-
dans TK21 was first screened by direct color observation. As a
result, many colonies (containing possible stimulatory ele-
ments) were selected, and their DNA fragments were success-
fully isolated. The transformants were roughly divided into five
groups according to their phenotypic characteristics: blue-pig-
mented colonies with well-developed aerial mycelia (group I),
pale blue- or red-pigmented colonies with well-developed aer-
ial mycelia (group II), nonpigmented or brown-pigmented col-
onies with well-developed aerial mycelia (group III), nonpig-
mented or brown-pigmented colonies with poorly developed
aerial mycelia (group IV), and blue-pigmented colonies with
poorly developed aerial mycelia (group V).
Among these five groups, only the members of group I, with
normal differentiation and increased pigment production (90
colonies out of 7,000 transformants), were considered for fur-
ther analysis. As such, these transformants imply the existence
of a class of regulators that act specifically on antibiotic pro-
duction but not on differentiation. In addition, they also sug-
gest that sporulation can be processed independently of anti-
biotic biosynthesis through a parallel genetic pathway (1). To
verify that the overproductions were based on the unique abil-
ity of each individual colony and rule out the effect of signal
molecules secreted by other colonies, each colony was re-
streaked on agar plates and inoculated into liquid medium. As
a result, only four transformants exhibited steady pigment pro-
duction, but the reason for this phenomenon is still unclear.
Finally, a DNA analysis of the four dark blue colonies revealed
that they all contained the same 8.0-kb DNA fragment, which
was designated S2.
Subcloning and quantitative analysis of pigment produc-
tion. A more detailed restriction map of the S2 fragment was
constructed, and the effect of subclones on actinorhodin and
undecylprodigiosin production was analyzed (Fig. 1). As shown
in Fig. 1, five subclones were generated from the S1 fragment,
which contained S2 and two small parts of pIJ702. Among the
subclones, only pPRA4, generated from the ligation of the S4
fragment (Table 1) with pIJ702, yielded dark blue colonies on
R2YE plates after transformation into S. lividans TK21. The
NS1, NS2, NS3, and NS4 fragments with the high-copy plasmid
pIJ487 were unable to stimulate pigmented-antibiotic produc-
tion on the same medium. The absence of pPRA2 or pPRA4
resulted in poor pigment production, yet these plasmids caused
a substantial increase in actinorhodin and undecylprodigiosin
production when they were reintroduced into S. lividans by
retransformation.
For quantitative analysis of pigment production induced by
the S2 fragment, the transformants of S. lividans TK21 carrying
pPRA2 (pIJ702 containing the S2 fragment) were cultured in
liquid YEME medium. The production of actinorhodin and
undecylprodigiosin was followed by spectrophotometric deter-
mination (13). After 2.5 to 3.5 days of growth at 30°C, the
production increased exponentially (Fig. 2). When the trans-
formants were cured of pPRA2, the amounts of the two pig-
ments produced were equal to those produced by plasmid-free
S. lividans. The retransformation of the cured strain with
pPRA2 induced a change in the color of the culture broth from
yellow to purple or dark blue. Originally, transformants of S.
lividans TK21 carrying pIJ702 were used as the control strain.
However, untransformed S. lividans was finally used because
melanin production confused the analysis of the pigment pro-
duction.
TABLE 2. Primers used in sequencing and PCR
Primer Nucleotide sequence (5 to 3) Position
Forward
S18F1 ACCTCCACTTCCGGTCGCTGA 128–148
S18F2 ATCCATCTCATTCTGGGCGTC 380–400
S33F1 TCGTGAGCAGCAGGTTGAGC 2024–2043
S33F2 AAACCATCGGCGTTGACGGT 2455–2474
S33F3 TCCCACACGTCGCCGATCAA 2805–2824
S33F4 ACGCCTGGTACGCGGCGTTC 3229–3248
S36F1 CCGGCAATGACTCGTCCCAC 5239–5258
S36F2 ACGGGCGTGCGGTGTCGAT 5536–5554
S36F3 TCTACACGGACCGGGTCATC 5871–5890
S36F4 CCGGGCACTTCGAGCACGTC 6192–6211
Reverse
S18R1 AAGTTCCGCAAGGACGGCGTA 876–856
S18R2 AACGGACGGCGTTCCTCGCC 1220–1201
S18R3 GGCAGTGAGCTCTTCGAGAA 1596–1577
S33R1 GACCTGGCGCACATCGGCAA 3751–3732
S33R2 AATCCGCTGTGGATCGAGGC 4131–4112
S33R3 TCGACCCGGCAGTACCTGTG 4548–4529
S33R4 TACGCCGCATTGCGGACCGT 4992–4973
S36R1 TCCGCAAGCCGGCCGACGCGAA 7456–7435
S36R2 AAGCTGGGTCTGATCGTCGA 7817–7798
PCR
Aac1 AAGCTCGAGAAGGCCCGATCCTT
GGAGCCC
pHP4545aac
Aac2 AAGCTCGAGCTCTTGAGTTAAGC
CGCGCCG
pHP4545aac
S36F5 AAGCCTTACCGTTTCACCCC 6827–6846
S36R2 AAGCTGGGTCTGATCGTCGA 7817–7798
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Effect of copy number of orfX-containing fragments on pig-
ment production. The stimulation of actinorhodin and unde-
cylprodigiosin production caused by the cloned 3.6-kb S4 frag-
ment exhibited a copy number dependency in S. lividans TK21.
When the effect of a low copy number was investigated with
pIJ941 (14) derived as pLS4 (Table 1) in the S. lividans strain,
no dark blue pigment was detected on the agar plates. The
absorbance of the pigmented antibiotics visibly increased in the
culture broth of S. lividans carrying pLS4 (Fig. 3A). However,
a moderate or high number of extrachromosomal copies of an
essential region containing orf41 and orfX, in pMS4 (Fig. 3B)
and pPRA4 (Fig. 3C), respectively, significantly increased pig-
ment production in the same host.
Enhancement of avermectin production by introduction of
cloned S2 fragment into wild-type S. avermitilis and its high-
producing mutant strains. Based on the copy number effect on
pigment production, it would appear that multiple fragment
copies can substantially increase avermectin production in S.
avermitilis. As expected, the high-copy-number plasmid
pPRA4 increased overall avermectin production the most
among the three S. avermitilis strains. The eight major aver-
mectin components were quantified in cultures of the wild type
and its high-producer mutants as well as their transformants
carrying the high-copy-number plasmid pPRA4 (Fig. 4). Plas-
mid pMS4 was found to be unsuitable for S. avermitilis because
the SLP1.2 origin seemed to prevent autonomous replication
in this Streptomyces species, as in S. coelicolor (13). In the case
of pLS4, plasmid replication was normally processed in S.
avermitilis, yet no detectable increase in avermectin production
was observed (data not shown).
Accordingly, these data prompted an investigation of the
effect of the 3.6-kb SacI-PstI region of S1 in the high-copy-
number plasmid pPRA4. Figure 4 shows that avermectin was
initially detected after 2 days of growth; thereafter, the level of
avermectin increased steadily during the exponential phase
and subsequent stationary phase. S. avermitilis carrying pPRA4
exhibited a profound increase in avermectin production, while
the level of avermectin production in the S. avermitilis trans-
formants carrying only pIJ702 remained unchanged. When the
transformants lost plasmid pPRA4, avermectin production re-
turned to the original level produced by the plasmid-free cells.
However, retransformation of the cured strain with pPRA4
restored increased antibiotic production. In the case of the
high-producing mutant strains ATCC 31780 and L-9, polyeth-
ylene glycol-mediated transformation with pPRA4 severely re-
duced overall avermectin production (Fig. 4C and D). These
reductions were found to be related to the removal and regen-
eration of the cell wall, which are essential for the polyethylene
glycol-mediated transformation procedure (9). Therefore, to
prevent this unnecessary decrease, the previously developed
electrotransformation procedure (9) was applied to these high-
producing strains with satisfactory results (Fig. 4C and D).
Analysis of nucleotide sequences. To sequence the 8.0-kb S2
fragment, three subclones were constructed, and the determi-
nation of the entire nucleotide sequence was completed
(EMBL accession number AF440828). A coding region anal-
ysis of the 7,996-bp sequence with the FramePlot (11) and PC
Gene programs revealed the presence of eight complete and
one incomplete ORF, which were named (from left to right)
imp1, imp2, orf46, orf45, orf44, orf43, orf42, orf41, and orfX
(Fig. 1). imp1, imp2, and orf42 were transcribed from right to
left, whereas orf46, orf45, orf44, orf43, orf41, and orfX were
FIG. 1. Restriction map, putative ORFs, and subcloned fragments of 8.0-kb DNA fragment (S2) of S. avermitilis activating both pigmented-
antibiotic production in S. lividans and avermectin production in S. avermitilis. The  and  symbols indicate the presence and absence of
avermectin production stimulation, respectively, during the growth of the wild-type S. avermitilis strain in MF medium.
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divergently transcribed. These genes exhibit the characteristics
of typical Streptomyces genes because they contain an overall
GC content of 72.0 mol% and 90.1% GC in the third-letter
position.
The putative ORFs and their features deduced from the
nucleotide sequences are summarized in Table 3. A similarity
search highlighted a significant similarity between the incom-
plete IMP1 and complete IMP2 proteins and the putative
integral membrane proteins IMP1 and IMP2 of S. coelicolor,
respectively. The sequences of the ORF46, ORF45, ORF44,
ORF43, ORF42, and ORF41 proteins showed high levels of
similarity with the hypothetical proteins of S. coelicolor. The
similarity or identity levels observed were within a range of 71
to 84% for the entire amino acid sequences. Unfortunately, the
S. coelicolor proteins homologous to ORF46, ORF45, ORF44,
ORF43, ORF42, and ORF41 from S. avermitilis are hypothet-
ical gene products, and thus their functions are unknown. The
orfX protein exhibited no significant similarity with any of the
proteins in the SWISSPROT and EMBL databases. A low
level of similarity (35% identity) was found between the orfX
protein and the putative membrane protein SC66T3.18c
(EMBL database accession number AL079348) of S. coeli-
color.
FIG. 2. Effect of 8.0-kb Sau3AI DNA fragment (S2) on pigment
production in S. lividans TK21 on 5-day-old R2YE plates (upper pan-
els) and in liquid YEME medium (lower panels). (A) TK21 carrying
no plasmid; (B) TK21 carrying pPRA2. The dark gray diffusion into
the agar medium indicates the blue pigment. (C) Production of acti-
norhodin (F) and undecylprodigiosin (E) by strain TK21 carrying no
plasmid (left side) or carrying plasmid pPRA2 (right side). The A530
and A590 values for undecylprodigiosin and actinorhodin were analyzed
and plotted. Each plot represents the mean values of duplicate exper-
iments. Bars indicate standard error.
FIG. 3. Effect of copy number of orfX-containing fragments on
pigment production in S. lividans TK21 cultured in liquid YEME
medium for 5 days. (A) , pIJ941; , pLS4 (pIJ941 containing 3.6-kb
EcoRI-PstI fragment of S1). (B) , pIJ61; , pMS4 (pIJ61 containing
2.7-kb BamHI-PstI fragment of S1). (C) , pIJ702; , pPRA4 (pIJ702
containing 3.6-kb SacI-PstI fragment of S2). Act, actinorhodin; Und,
undecylprodigiosin.
FIG. 4. Overall avermectin production in wild-type S. avermitilis (A
and B), high-producer strain ATCC 31780 (C), and semi-industrial
strain L-9 (D) cultured in modified MF medium for 8 days. Symbols:
, no plasmid; Œ, orfX disrupted; F, pPRA4 introduced by electropo-
ration of intact cells; E, pPRA4 introduced by polyethylene glycol-
mediated transformation; , pIJ702 introduced by polyethylene glycol-
mediated transformation. Thiostrepton addition had no effect on the
growth of the transformants, and each plot represents the mean values
of three independent experiments. Bars indicate standard error.
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Accordingly, compared to the arrangement of the S. coeli-
color chromosome, the current results suggest that a chromo-
somal rearrangement of S. avermitilis may have occurred as a
result of internal genetic instability. So far, no homology has
been found in the ongoing but still incomplete S. avermitilis
genome sequencing (10, 19). However, since a database search
is insufficient to elucidate the whole function of the large DNA
fragment, as many of the functions of the Streptomyces proteins
are still in question, further research, including disruption of
each ORF, protein isolation, characterization, and comparison
of the effects between orfX and aver, is needed to provide a
more accurate answer to why multiple copies of the S2 frag-
ment and orfX-containing fragments caused an increase in
antibiotic production, as described previously.
Distribution of orfX sequence among avermectin-high-pro-
ducing mutant strains. To identify the distribution of the orfX
sequence among high-producing S. avermitilis strains, a PCR
analysis with the internal primers S36F5 and S36R2 (Table 2)
was performed. A 973-bp orfX region of the S4 fragment was
used as the target. The amplified bands were found in the
wild-type strain ATCC 31267 as well as in the high avermectin
producers ATCC 31780 and L-9 (data not shown). These re-
sults, together with the results of the gene disruption experi-
ment, strongly suggest that either the entire sequence or a
considerably conserved sequence of orfX exists in the high
producers and that the orfX product appears to play an essen-
tial role in the production and regulation of avermectin in both
the normal strain and the high producers.
Construction of orfX disruptant. To investigate the possible
role of the orfX gene product in S. avermitilis, nucleotide se-
quencing was performed and an orfX disruptant was generated
by insertional inactivation, as described in Materials and Meth-
ods. The finally constructed vector, pS2S-tsr-aac, contained the
orfX gene interrupted at a unique XhoI site by the aac gene
oriented in the direction of the transcription of orfX. pS2S-tsr-
aac was used to transform protoplasts of S. avermitilis ATCC
31267 for the disruption of orfX in its chromosome (Fig. 5).
The orfX-disrupted S. avermitilis strain ATCC 31267 grew and
sporulated normally on modified YM agar medium. However,
the amount of avermectin produced by the disruptant was less
than that produced by the wild-type S. avermitilis ATCC 31267
both on agar medium and in liquid culture (Fig. 4B). As such,
the disruption of the orfX gene resulted in a significant yet
incomplete loss of avermectin production, and the negative
effect of the disruption on avermectin production was similar
to other examples of positive regulatory gene disruption (8, 16,
17, 23).
As expected, retransformation of the orfX-disrupted mutant
with pPRA4 restored its avermectin production ability, imply-
ing that the mutation was compensated for by the introduction
of this plasmid. However, because pPRA4 carrying both orfX
and orf41 was used to complement the null mutant, the gen-
tamicin resistance cassette could have polar effects on orf41,
and thus the avermectin restoration could be the result of the
introduction of orfX or a combination of orfX and orf41. The
former and latter results indicate that the orfX gene is required
FIG. 5. Schematic presentation of construction of orfX mutant. (A) Restriction map and mutagenesis of orfX by insertion of gentamicin
resistance gene (aac). (B) Confirmation of insertion of aac gene into orfX by PCR analysis with internal primers S36F5 and S36R2. Wt, wild-type
strain; Mut, orfX mutant. Sizes are shown in kilobases.
TABLE 3. Relevant features deduced from DNA sequences
ORF Homologous protein (% similarity) Initiation-stop codons No. of amino acids Predicted function
imp1 S. coelicolor SC10H5.02c (71) 148 TGA 49 Integral membrane protein
imp2 S. coelicolor SC10H5.03c (68) ATG182–628TGA 149 Integral membrane protein
orf46 S. coelicolor SCM1.46 (78) GTG1764–763TGA 333 Unknown
orf45 S. coelicolor SCM1.45 (78) ATG2588–1761TGA 275 Unknown
orf44 S. coelicolor SCM1.44 (82) ATG3910–2588TGA 441 Unknown
orf43 S. coelicolor SCM1.43 (74) GTG5205–3907TGA 433 Unknown
orf42 S. coelicolor SCM1.42c (72) GTG5466–6341TGA 291 Unknown
orf41 S. coelicolor SCM1.41 (84) GTG6750–6295TGA 151 Unknown
orfX S. coelicolor SC66T3.18c (35) ATG7823–6840TGA 327 Putative membrane protein
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for the stimulation of avermectin production, while the other
gene(s) in the S2 fragment appears to have more of an assisting
role in avermectin production.
DISCUSSION
The primary goal of the present study was to enhance aver-
mectin production through cloning and manipulating a stimu-
latory genetic element instead of the traditional methods for
strain development, for example, random mutagenesis and ge-
nome recombination by protoplast fusion. Although S. aver-
mitilis is considered an industrially important Streptomyces
strain, comprehensive studies on the essential molecular fac-
tors influencing avermectin productivity are still incomplete.
To clone a stimulatory gene positively affecting avermectin
production, a genomic DNA library of S. avermitilis was con-
structed and an 8.0-kb DNA fragment which stimulated acti-
norhodin and undecylprodigiosin production in S. lividans
TK21 was successfully isolated. It was particularly interesting
that the same DNA fragment also increased avermectin bio-
synthesis in various S. avermitilis strains, including the high-
producing mutant strain ATCC 31780 and a semi-industrial
strain L-9.
To verify the enhancing effect caused by this large DNA
fragment, DNA sequencing and molecular biological analyses
were performed. The subcloning of fragments into various
vectors with different copy numbers, gene disruption (inser-
tional inactivation) of a determinant region, and comparison of
the sequences with known sequences in the databases demon-
strated that a DNA region containing orfX and orf41 was es-
sential for the stimulatory effect and that orfX may be a mem-
brane-bound putative regulatory gene. A comparison of the
ORFs in the 8.0-kb S. avermitilis DNA with the chromosome
sequence of S. coelicolor A3(2) revealed that homologous
counterparts to the ORFs were scattered all over the S. coeli-
color genome (SCM1, SC66T3, and SC10H5), suggesting the
possibility that this distribution was caused by severe genetic
rearrangement in S. avermitilis. As such, it will be interesting to
investigate the relationship between aveR (a putative pathway-
specific regulatory gene for avermectin production) (10) and
the cloned genes, especially orfX.
The current examples of yield enhancement based on the
isolation and manipulation of a stimulatory factor in a rela-
tively high-producing strain and a semi-industrial strain are
indeed encouraging and meaningful to the microbial and bio-
technological field as this approach can be applied directly to
numerous industrial strains.
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ERRATUM
Cloning and Analysis of a DNA Fragment Stimulating Avermectin Production
in Various Streptomyces avermitilis Strains
Yong-Soon Hwang, Eung-Soo Kim, Sa´ndor Biro´, and Cha-Yong Choi
School of Chemical Engineering, Seoul National University, Seoul, and Division of Chemical Science and Biological Engineering,
Inha University, Inchon, Korea, and Department of Human Genetics, Medical and Health Science Center,
University of Debrecen, H-4012 Debrecen, Hungary
Volume 69, no. 2, p. 1263–1269, 2003. Page 1267: In Fig. 2, panel A should be labeled B and panel B should be labeled A.
3024
 by on M
arch 13, 2010 
a
e
m
.a
sm
.o
rg
D
ow
nloaded from
 
